Valuation: Cencora, Inc.

Market Cap 62.03B 55.53B 51.77B 46.95B 88.56B 5,930B 89.11B 622B 244B 3,060B 233B 228B 9,847B P/E 2026 *
17.8x
P/E 2027 * 18.9x
Enterprise Value 69.72B 62.41B 58.18B 52.77B 99.54B 6,665B 100B 699B 274B 3,439B 262B 256B 11,068B EV / Sales 2026 *
0.21x
EV / Sales 2027 * 0.2x
Free-Float
61.21%
Yield 2026 *
0.73%
Yield 2027 * 0.75%
1 day+0.37%
1 week+3.22%
Current month+8.26%
1 month+1.09%
3 months+7.12%
6 months+1.32%
Current year-3.76%
1 week 314.9
Extreme 314.9
327.96
1 month 295.01
Extreme 295.01
327.96
Current year 244.82
Extreme 244.82
376.92
1 year 244.82
Extreme 244.82
377.54
3 years 182.75
Extreme 182.75
377.54
5 years 113.68
Extreme 113.68
377.54
10 years 68.38
Extreme 68.38
377.54
Manager TitleAgeSince
Chief Executive Officer 59 30/09/2024
Director of Finance/CFO 59 28/06/2026
Chief Tech/Sci/R&D Officer 50 03/11/2024
Director TitleAgeSince
Director/Board Member 75 15/05/2013
Director/Board Member 59 30/09/2024
Chairman 64 30/09/2025
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Other

Director

275 0.0001%
01/10/26 Sell

Controller/Auditor

-986 0.0005%
01/10/26 Other

Director

197 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+3.22%+2.22%+73.30% 62.03B
+2.23%+1.72%-23.20%+12.89% 176B
+3.90%+4.50%-3.69%+28.95% 118B
+1.90%-0.92%-22.49%+11.33% 108B
-0.17%-0.14%-46.65%-10.73% 75.34B
+1.04%+0.06%+19.35%+61.96% 52.8B
+2.80%+4.55%+1.25%-26.52% 51.45B
+1.15%-0.59%-14.97%+22.33% 41.28B
-1.38%-0.11% - - 31.37B
+2.15%-1.13%+31.94%+13.82% 32.42B
Average +0.97%+1.80%-6.25%+20.81% 74.89B
Weighted average by Cap. +1.12%+2.01%-12.31%+19.40%

Financials

2026 *2027 *
Net sales 337B 302B 281B 255B 481B 32,217B 484B 3,380B 1,323B 16,626B 1,266B 1,238B 53,501B 352B 315B 294B 266B 502B 33,641B 506B 3,529B 1,382B 17,360B 1,322B 1,293B 55,864B
Net income 3.58B 3.21B 2.99B 2.71B 5.11B 342B 5.14B 35.91B 14.06B 177B 13.45B 13.15B 568B 3.28B 2.93B 2.73B 2.48B 4.68B 313B 4.71B 32.86B 12.86B 162B 12.31B 12.04B 520B
Net Debt 7.69B 6.88B 6.42B 5.82B 10.98B 735B 11.05B 77.13B 30.19B 379B 28.89B 28.25B 1,221B 9.44B 8.45B 7.87B 7.14B 13.47B 902B 13.56B 94.64B 37.05B 465B 35.45B 34.66B 1,498B
Projected Income Statement - Annual - Cencora, Inc.
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change Volume
12/10/26 US$325.06 +0.37% 959,158
09/10/26 US$323.85 +0.78% 781,945
08/10/26 US$321.35 +1.29% 897,578
07/10/26 US$317.25 +0.28% 1,060,756
06/10/26 US$316.37 +0.46% 817,905
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Cencora, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
325.06USD
Average target price
369.92USD
Spread / Average Target
+13.80%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Cencora, Inc.